Mortality and prostate cancer risk in 19,598 men after surgery for benign prostatic hyperplasia

BJU International

Volumn 84, Issue 1, 1999, Pages 37-42

  Holman, C D J ^a   Wisniewski, Z S ^b   Semmens, J B ^a   Rouse, I L ^c   Bass, A J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Quality of Surgical Care Committee   (Australia)

^c Health Information Centre   (Australia)

Author keywords

Benign prostatic hyperplasia; Mortality; Outcomes; Prostate cancer; Prostatectomy; Record linkage; TURP

Indexed keywords

ADULT; AGE; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COMORBIDITY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; REGRESSION ANALYSIS; SURGICAL MORTALITY; SURVIVAL; TRANSURETHRAL RESECTION;

HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SURVIVAL RATE;

EID: 0032808358     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1999.00123.x     Document Type: Article

References (35)

1. 1 Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-9
2. 2 Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC, Writing Committee. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243-7
3. 3 Wennberg JE, Roos N, Sola L, Schori A, Jaffe R. Use of claims data systems to evaluate health care outcomes. JAMA 1987; 257: 933-6
4. 4 Roos NP, Ramsey EW. A population-based study of prostatectomy: outcomes associated with differing surgical approaches. J Urol 1987; 137: 1184-8
5. 5 Roos NP, Wennberg JE, Malenka DJ et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. New Eng J Med 1989; 320: 1120-4
6. 6 Roos LL, Fisher ES, Sharp SM, Newhouse JP, Anderson G, Bubolz TA. Postsurgical mortality in Manitoba and New England. JAMA 1990; 263: 2453-8
7. 7 Andersen TF, Bronnum-Hansen H, Sejr T, Roepstorff C. Elevated mortality following transurethral resection of the prostate for benign hypertrophy! But why? Medical Care 1990; 28: 870-81
8. 8 Taylor Z, Krakauer H. Mortality and reoperation following prostatectomy: outcomes in a Medicare population. Urology 1991; 38 (Suppl): 27-31
9. 9 Stephenson WP, Chute CG, Guess HA, Schwartz S, Lieber M. Incidence and outcome of surgery for benign prostatic hyperplasia among residents of Rochester, Minnesota 1980-87. Urology 1991; 38 (Suppl): 32-42
10. 10 Sidney S, Quesenberry CP, Sadler MC, Cattolica EV, Lydick EG, Guess HA. Reoperation and mortality after surgical treatment of benign prostatic hypertrophy in a large prepaid medical care program. Medical Care 1992; 30: 117-25
11. 11 Concato J, Horwitz RI, Feinstein AR, Elmore JG, Schiff SF. Problems of comorbidity in mortality after prostatectomy. JAMA 1992; 267: 1077-82
12. 12 Thorpe AC, Cleary R, Coles J, Vernon S, Reynolds J, Neal DE. Deaths and complications following prostatectomy in 1400 men in the Northern Region of England. Br J Urol 1994; 74: 559-65
13. 13 Koshiba K, Egawa S, Ohori M, Uchida T, Yokoyama E, Shoji K. Does transurethral resection of the prostate pose a risk to life? 22-year outcome. J Urol 1995; 153: 1506-9
14. 14 Seagroatt V. Mortality after prostatectomy: selection and surgical approach. Lancet 1995; 346: 1521-4
15. 15 Crowley AR, Horowitz M, Chan E, Macchia RJ. Transurethral resection of the prostate versus open prostatectomy: long-term mortality comparison. J Urol 1995; 153: 695-7
16. 16 Hargreave TB, Heynes CF, Kendrick SW, Whyte B, Clarke JA. Mortality after transurethral and open prostatectomy in Scotland. Br J Urol 1996; 77: 547-53
17. 17 Hammarsten J, Andersson S, Holmen A, Hogstedt B, Peeker R. Does transurethral resection of a clinically benign prostate gland increase the risk of developing clinical prostate cancer? A 10-year follow-up study. Cancer 1994; 74: 2347-451
18. 18 Semmens JB, Lawrence-Brown MMD, Fletcher DR, Rouse IL, Holman CDJ. The Quality of Surgical Care Project: a model to evaluate surgical outcomes in Western Australia using population-based record linkage. Aust NZ J Surg 1998; in press
19. 19 National Coding Centre. Australian Version of The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). Sydney: National Coding Centre, 1995
20. 20 World Health Organization. International Classification of Procedures in Medicine. Geneva: World Health Organization, 1978
21. 21 World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. Geneva: World Health Organization, 1977
22. 22 Norusis MJ. SPSS for Windows. Base System User's Guide Release 5.0. Chicago: SPSS Inc., 1992
23. 23 Therneau T, Sicks J, Bergstralh E, Offord J. Expected survival based on hazard rates. Rochester, Minnesota: May Clinic Section of Biostatistics Technical Report #52, March 1994
24. 24 Hakulinen T. On long term relative survival rates. J Chron Dis 1977; 30: 431-43
25. 25 Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Computer Programs in Biomedicine 1985; 19: 197-207
26. 26 Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-83
27. 27 Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993; 46: 1075-9
28. 28 Miettinen OS. Stratification by multivariate confounder score. Am J Epidemiol 1976; 104: 609-20
29. 29 Lemeshow S, Tepes D, Avrunin JS, Pastiden IT. Predicting the outcome of intensive care unit patients. J Am Stat Ass 1988; 83: 348-56
30. 30 Royston P, Altman GD. Regression using fractional polynomials. Appl Statistics 1994; 43: 429-67
31. 31 Robertson C, Boyle P, Hsieh C-C, Macfarlane GJ, Maisonneuve P. Some statistical considerations in the analysis of case-control studies when exposure variables are continuous measurements. Epidemiology 1994; 5: 164-70
32. 32 Guess HA. Benign prostatic hyperplasia: antecedents and natural history. Epidemiol Rev 1992; 14: 131-53
33. 34 Anson K, Nawrocki J, Buckley J et al. A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995; 46: 305-10
34. 35 National Health and Medical Research Council. Clinical Practice Guidelines. The Management of Uncomplicated Lower Urinary Tract Symptoms in Men. December 1996. Canberra: Australian Government Publishing Service, 1997
35. 33 Cowles RS, Kabalin JN, Childs S et al. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995; 46: 155-60